DKK4 and gastrointestinal stromal tumor: Aberrant activation of Wnt pathway has been documented in advanced GIST previously.19, 20 However, the canonical Wnt signaling antagonist DKK4 appeared to be strongly correlated with patients’ risk stratification during our screening, which arouse our great interests.